OpenEvidence Launches AI-Integrated Doctor Dialer, Expanding Telehealth Capabilities

MIAMI, Feb. 26, 2026 – OpenEvidence, recognized as the most valuable doctor technology company globally and lauded by the New England Journal of Medicine for its clinical decision AI, today announced the wide release of its AI-Integrated Doctor Dialer™. This HIPAA-secure communications suite is designed to streamline doctor-patient interactions through telemedicine calls, messaging, faxing, and voicemail outreach, all integrated within the OpenEvidence app.

AI-Powered Clinical Workflow Integration

The OpenEvidence AI-Integrated Doctor Dialer™ utilizes multi-step AI throughout the clinical workflow, from call documentation to real-time clinical decision support during patient interactions. Evidence-based recommendations are embedded directly within patient notes generated from each call, providing AI assistance at every stage of care.

Addressing Communication Challenges

Unlike traditional, fragmented communication tools, the OpenEvidence Dialer aims to improve the efficiency and accuracy of clinical communications. It integrates OpenEvidence’s Clinical Decision AI – used by more American doctors than all other AIs combined – directly into the patient communications workflow. This allows clinicians to communicate, document, and navigate clinical decisions with real-time AI support, even during private telemedicine calls.

Early Adoption and Impact

Even in its limited release, the OpenEvidence doctor-patient Visits™ suite has powered approximately 37 million minutes of doctor-patient care communications in the United States over the past several months. The Dialer was initially developed to address the challenge of balancing clinician privacy with patient accessibility, allowing healthcare professionals to communicate securely while protecting their personal phone numbers.

Key Features of the OpenEvidence Dialer

• Customizable Caller ID: Place calls with a hospital or practice number to increase patient pickup rates while maintaining personal privacy.
• Seamless Telemedicine Integration: Connect with patients over telemedicine with a single tap.
• Multi-Profile Support: Switch seamlessly between profiles and phone numbers across multiple hospitals or clinics.
• Secure Messaging: Send and receive secure text messages directly within the OpenEvidence app.
• Integrated Faxing: Send and receive faxes by uploading files or scanning documents.
• Straight-to-Voicemail: Deliver messages directly to voicemail for non-urgent communications.
• Automated Clinical Notes: Automatically transcribe patient calls into structured documentation with real-time evidence integration using OpenEvidence Visits™.

HIPAA Compliance and Accessibility

All communications through the OpenEvidence Dialer remain fully HIPAA-compliant. The Dialer includes unlimited daily minutes and is available for free to all verified U.S. Healthcare professionals within the OpenEvidence app. Users can access the Dialer by tapping “Dialer” on the navigation bar.

About OpenEvidence

OpenEvidence was named “the best AI tool for medical information” by the New England Journal of Medicine JW. Independent studies indicate that OpenEvidence is used by more American doctors than all other AI platforms combined. OpenEvidence is a clinical decision support platform designed to provide healthcare professionals with real-time, evidence-based answers and streamline clinical workflows within a secure, HIPAA-compliant environment. The company is backed by leading investors including Google, Nvidia, and Sequoia Capital.

About OpenEvidence AI-Integrated Doctor Dialer™

The OpenEvidence AI-Integrated Doctor Dialer™ is available on the OpenEvidence app for iOS and Android, offering HIPAA-secure calling, messaging, faxing, and voicemail capabilities. The Dialer allows clinicians to call patients using their hospital or practice number, protecting their personal phone number. Integration with OpenEvidence Visits™ enables automatic clinical note creation from calls.

Media Contact: [email protected]

SOURCE OpenEvidence